Risk Stratification tool for Healthcare workers during the CoViD-19 Pandemic; using published data on demographics, co-morbid disease and clinical domain in order to assign biological risk
Janusz Jankowski, Angharad Davies, Peter MB English, Ellis Friedman, Helena McKeown, Mala Rao, Su Sethi, View ORCID ProfileW. David Strain
doi: https://doi.org/10.1101/2020.05.05.20091967
Janusz Jankowski
1Sherwood Forest Hospitals NHS Foundation Trust, Nottinghamshire
2Comprehensive Clinical trials Unit, University College London
3Department of Life Sciences, Roehampton University, London
4Consultant Committee, British Medical Association, London
Angharad Davies
5Swansea University Medical School, Swansea
6Medical Academic Staff Committee, British Medical Association, London
Peter MB English
7Public Health Medicine Committee, British Medical Association, London
Ellis Friedman
4Consultant Committee, British Medical Association, London
8Faculty of Public Health, UK
Helena McKeown
9Portfolio GP, Wiltshire
10Chair of Representative body, British Medical Association, London
Mala Rao
4Consultant Committee, British Medical Association, London
11Imperial College, London
OBESu Sethi
4Consultant Committee, British Medical Association, London
12North West Commissioning Team, Liverpool
W. David Strain
6Medical Academic Staff Committee, British Medical Association, London
13College of Medicine and Health, University of Exeter
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted May 20, 2020.
Risk Stratification tool for Healthcare workers during the CoViD-19 Pandemic; using published data on demographics, co-morbid disease and clinical domain in order to assign biological risk
Janusz Jankowski, Angharad Davies, Peter MB English, Ellis Friedman, Helena McKeown, Mala Rao, Su Sethi, W. David Strain
medRxiv 2020.05.05.20091967; doi: https://doi.org/10.1101/2020.05.05.20091967
Risk Stratification tool for Healthcare workers during the CoViD-19 Pandemic; using published data on demographics, co-morbid disease and clinical domain in order to assign biological risk
Janusz Jankowski, Angharad Davies, Peter MB English, Ellis Friedman, Helena McKeown, Mala Rao, Su Sethi, W. David Strain
medRxiv 2020.05.05.20091967; doi: https://doi.org/10.1101/2020.05.05.20091967
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)